Tag: ADOCIA
Unusual volumes on the stock market today: Adocia
During this trading session on Monday August 21, 2023, particularly high trading volumes were detected on the French market. Today, it is the Adocia share that stands out, with trading…
ADOCIA confirms its eligibility for the PEA-PME – 07/18/2023 at 18:00
ADOCIA confirms its eligibility for the PEA-PME 6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic…
ADOCIA: Information relating to the number of shares and voting rights as of June 30, 2023 – 07/12/2023 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of June 30, 20236 p.m. CEST – In accordance with the provisions of Article L.233-8 II of the…
ADOCIA grants Sanofi an exclusive right to negotiate a partnership on M1Pram for 10 million euros and obtains the commitment of investors for a fundraising of 10 million euros – 07/05/2023 at 18:34
• Sanofi pays the sum of 10 million euros to Adocia in return for an exclusive trading right on the M1Pram product with a view to a global partnership• Adocia…
ADOCIA: Information relating to the number of shares and voting rights as of May 31, 2023 – 06/16/2023 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of May 31, 2023. 6 p.m. CEST – In accordance with the provisions of Article L.233-8 II of…
ADOCIA: Information relating to the number of shares and voting rights as of February 28, 2023 – 03/17/2023 at 6:00 p.m.
6 p.m. CET – In accordance with the provisions of Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés…
Adocia: cash of 17.4 million euros at the end of 2022, visibility until September 2023 – 03/15/2023 at 18:27
(AOF) – Adocia, a biotech company specializing in the treatment of diabetes and other metabolic diseases, announces that its cash position was 17.4 million euros at December 31, 2022, compared…
Adocia: the CDC falls below 10% of the capital – 01/20/2023 at 14:57
(CercleFinance.com) – The Caisse des dépôts et consignations (CDC) declared to the AMF that it crossed downwards, on January 16, through Bpifrance Investissement, which acts on behalf of the Innobio…
ADOCIA: Information relating to the number of shares and voting rights as of December 31, 2022 – 01/16/2023 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of December 31, 2022. 6:00 p.m. CET – In accordance with the provisions of Article L.233-8 II of…
ADOCIA announces its financial calendar for the year 2023 – 01/12/2023 at 18:00
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…
ADOCIA announces the positive results of a Phase 1 study on BioChaperone® Lispro with its partner Tonghua Dongbao – 2022-12-29 at 08:00
• Adocia’s partner, Tonghua Dongbao, announced that the primary endpoint of this Phase 1 study has been met and that the results confirmed an accelerated profile of BioChaperone® Lispro compared…
Adocia announces the positive results of a study on BioChaperone Lispro – 29/12/2022 at 08:38
(AOF) – Adocia, a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, today announces new positive…